Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Journal of Pediatric Surgery|October 1, 2013
Potential benefits of fast-track concepts in paediatric colorectal surgeryMalcolm A West, James F Horwood, Sally Staves, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Postmarketing surveillance of the safety of cimetidine: 15-year mortality reportJ Beresford, D G Colin-Jones, A C Flind, et al.
Clinical Oral Investigations|October 5, 2024
Effective doses of scout projections in maxillofacial cone beam computed tomographyMatheus Barros-Costa, Jack Britten, Colin Jones, et al.
Lancet (London, England)|April 30, 1994
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugsM J Langman, J Weil, P Wainwright, et al.
Gut|June 13, 2003
Mortality study of 18 000 patients treated with omeprazoleD N Bateman, D Colin-Jones, S Hartz, et al.
BMC Public Health|June 5, 2015
Evaluation of work-based screening for early signs of alcohol-related liver disease in hazardous and harmful drinkers: the PrevAIL studyPenny A Cook, Michela Morleo, David Billington, et al.
Plos Neglected Tropical Diseases|January 17, 2020
Under-detection of blood culture-positive enteric fever cases: The impact of missing data and methods for adjusting incidence estimatesMerryn Voysey, Dikshya Pant, Mila Shakya, et al.
The American Journal of Medicine|November 19, 1984
Reducing overnight secretion of acid to heal duodenal ulcers. Comparison of standard divided dose of ranitidine with a single dose administered at nightD G Colin-Jones, A Ireland, P Gear, et al.
Lancet (London, England)|August 4, 1984
Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcersA Ireland, D G Colin-Jones, P Gear, et al.
Gut|December 22, 1999
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugsJ Weil, M J Langman, P Wainwright, et al.
Pageof 12